Acasti Pharma Inc.
Profile
Mailing Address: 545 Promenade du Centropolis
Suite 100
Laval, Québec
H7T 0A3
Head Office Address: 545 Promenade du Centropolis
Suite 100
Laval, Québec
H7T 0A3
Contact Name: Jean-Daniel Belanger Principal Regulator: Quebec
Business e-mail address: j-d.belanger@neptunebiotech.com Short Form Prospectus Issuer: Yes
Telephone Number: 450 687-2262 Reporting Jurisdictions: British Columbia, Alberta, Manitoba, Ontario, Quebec
Fax Number: 450 687-2272 Stock Exchange: NASDAQ, TSX Venture
Date of Formation: Feb 1 2002 Stock Symbol: ACST
Jurisdiction Where Formed: Québec Auditor: KPMG, LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 00430K Transfer Agent: Computershare trust company of Canada
Financial Year-End: Mar 31 Size of Issuer (Assets): Under $5,000,000


View This Company's Documents